Previous close | 4.0500 |
Open | 2.7500 |
Bid | 1.4000 |
Ask | 5.8000 |
Strike | 100.00 |
Expiry date | 2026-01-16 |
Day's range | 2.7500 - 3.0000 |
Contract range | N/A |
Volume | |
Open interest | 158 |
Fady Malik, Executive Vice President of Research & Development at Cytokinetics Inc (NASDAQ:CYTK), sold 7,788 shares of the company on June 11, 2024.
On June 10, 2024, Muna Bhanji, a Director at Cytokinetics Inc (NASDAQ:CYTK), sold 2,000 shares of the company at a price of $52.07 per share.
On June 3, 2024, B Parshall, Director at Cytokinetics Inc (NASDAQ:CYTK), executed a sale of 5,000 shares of the company.